304 related articles for article (PubMed ID: 15938631)
1. Investigating DNA adduct-targeted mutagenicity of tamoxifen: preferential formation of tamoxifen-DNA adducts in the human p53 gene in SV40 immortalized hepatocytes but not endometrial carcinoma cells.
Besaratinia A; Pfeifer GP
Biochemistry; 2005 Jun; 44(23):8418-27. PubMed ID: 15938631
[TBL] [Abstract][Full Text] [Related]
2. Mutational signature of the proximate bladder carcinogen N-hydroxy-4-acetylaminobiphenyl: inconsistency with the p53 mutational spectrum in bladder cancer.
Besaratinia A; Bates SE; Pfeifer GP
Cancer Res; 2002 Aug; 62(15):4331-8. PubMed ID: 12154037
[TBL] [Abstract][Full Text] [Related]
3. Similar mutagenicity of photoactivated porphyrins and ultraviolet A radiation in mouse embryonic fibroblasts: involvement of oxidative DNA lesions in mutagenesis.
Besaratinia A; Bates SE; Synold TW; Pfeifer GP
Biochemistry; 2004 Dec; 43(49):15557-66. PubMed ID: 15581368
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of the mutagenicity of benzo(a)pyrene diol epoxide by a nonmutagenic dose of ultraviolet A radiation.
Besaratinia A; Pfeifer GP
Cancer Res; 2003 Dec; 63(24):8708-16. PubMed ID: 14695185
[TBL] [Abstract][Full Text] [Related]
5. Mutation spectra induced by alpha-acetoxytamoxifen-DNA adducts in human DNA repair proficient and deficient (xeroderma pigmentosum complementation group A) cells.
McLuckie KI; Crookston RJ; Gaskell M; Farmer PB; Routledge MN; Martin EA; Brown K
Biochemistry; 2005 Jun; 44(22):8198-205. PubMed ID: 15924439
[TBL] [Abstract][Full Text] [Related]
6. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP
Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742
[TBL] [Abstract][Full Text] [Related]
7. DNA damage, repair, and mutation induction by (+)-Syn and (-)-anti-dibenzo[a,l]pyrene-11,12-diol-13,14-epoxides in mouse cells.
Yoon JH; Besaratinia A; Feng Z; Tang MS; Amin S; Luch A; Pfeifer GP
Cancer Res; 2004 Oct; 64(20):7321-8. PubMed ID: 15492252
[TBL] [Abstract][Full Text] [Related]
8. G-to-T transversions and small tandem base deletions are the hallmark of mutations induced by ultraviolet a radiation in mammalian cells.
Besaratinia A; Synold TW; Xi B; Pfeifer GP
Biochemistry; 2004 Jun; 43(25):8169-77. PubMed ID: 15209513
[TBL] [Abstract][Full Text] [Related]
9. Organ specificity of DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment.
Phillips DH; Hewer A; Osborne MR; Cole KJ; Churchill C; Arlt VM
Mutagenesis; 2005 Jul; 20(4):297-303. PubMed ID: 15928012
[TBL] [Abstract][Full Text] [Related]
10. Adducts and tamoxifen.
Busch H
Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-98-S1-104. PubMed ID: 9045322
[TBL] [Abstract][Full Text] [Related]
11. Mutagenic potential of alpha-(N2-deoxyguanosinyl)tamoxifen lesions, the major DNA adducts detected in endometrial tissues of patients treated with tamoxifen.
Terashima I; Suzuki N; Shibutani S
Cancer Res; 1999 May; 59(9):2091-5. PubMed ID: 10232593
[TBL] [Abstract][Full Text] [Related]
12. Lack of mutagenicity of acrolein-induced DNA adducts in mouse and human cells.
Kim SI; Pfeifer GP; Besaratinia A
Cancer Res; 2007 Dec; 67(24):11640-7. PubMed ID: 18089793
[TBL] [Abstract][Full Text] [Related]
13. Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice.
Zimmer DM; Harbach PR; Mattes WB; Aaron CS
Environ Mol Mutagen; 1999; 33(3):249-56. PubMed ID: 10334627
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen induces G:C-->T:A mutations in the cII gene in the liver of lambda/lacI transgenic rats but not at 5'-CpG-3' dinucleotide sequences as found in the lacI transgene.
Davies R; Gant TW; Smith LL; Styles JA
Carcinogenesis; 1999 Jul; 20(7):1351-6. PubMed ID: 10383911
[TBL] [Abstract][Full Text] [Related]
15. The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts.
Denissenko MF; Koudriakova TB; Smith L; O'Connor TR; Riggs AD; Pfeifer GP
Oncogene; 1998 Dec; 17(23):3007-14. PubMed ID: 9881702
[TBL] [Abstract][Full Text] [Related]
16. Slow repair of bulky DNA adducts along the nontranscribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers.
Denissenko MF; Pao A; Pfeifer GP; Tang M
Oncogene; 1998 Mar; 16(10):1241-7. PubMed ID: 9546425
[TBL] [Abstract][Full Text] [Related]
17. Sequence distribution of acetaldehyde-derived N2-ethyl-dG adducts along duplex DNA.
Matter B; Guza R; Zhao J; Li ZZ; Jones R; Tretyakova N
Chem Res Toxicol; 2007 Oct; 20(10):1379-87. PubMed ID: 17867647
[TBL] [Abstract][Full Text] [Related]
18. Review of the toxicology of tamoxifen.
Wogan GN
Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-87-S1-97. PubMed ID: 9045321
[TBL] [Abstract][Full Text] [Related]
19. Excision of tamoxifen-DNA adducts by the human nucleotide excision repair system.
Shibutani S; Reardon JT; Suzuki N; Sancar A
Cancer Res; 2000 May; 60(10):2607-10. PubMed ID: 10825130
[TBL] [Abstract][Full Text] [Related]
20. In vivo mutagenicity and hepatocarcinogenicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in bitransgenic c-myc/lambda lacZ mice.
Ryu DY; Pratt VS; Davis CD; Schut HA; Snyderwine EG
Cancer Res; 1999 Jun; 59(11):2587-92. PubMed ID: 10363978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
